Predictive Oncology Inc
Predictive Oncology Inc. is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Stock Performance Snapshot
Analyst Rating
Analysts suggest keeping Predictive Oncology's stock as it shows limited growth potential.
Financial Health
Predictive Oncology Inc is generating moderate revenue and profit margins, with a positive cash flow.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring POAI
AI-Driven Drug Discovery
These groundbreaking companies are redefining pharmaceutical research with artificial intelligence. Each has been carefully selected by our analysts for their potential to develop life-saving drugs faster and more efficiently than traditional methods allow.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
AI‑driven research
Combines machine learning with biological models to speed experimental decisions; however, technical validation is ongoing and results can vary.
Early‑stage upside
Partnerships or successful validation could drive value, but investors should expect volatility and the possibility of capital raises.
Industry relevance
Works in oncology research where demand for predictive tools is growing, though commercial adoption and regulatory paths can be uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
